Sara Yankelev

Sara Yankelev is a seasoned biostatistician with extensive experience in the pharmaceutical industry. Currently serving as a Principal Biostatistician at Merck Group since March 2015, Sara has also held multiple roles at Cubist Pharmaceuticals, including Principal Biostatistician and Senior Biostatistician II. Prior experience includes a position as Senior Biostatistician at Abt Associate Clinical Trials and a decade-long tenure as a Staff Scientist at Genetics Institute/Wyeth Pharmaceuticals. Educational qualifications include a Master of Public Health in Biostatistics and Epidemiology from Boston University and a degree from The Hebrew University of Jerusalem.